Also trades as: 0K1R.L (LSE) · $vol 0M
VRDN NASDAQ
Viridian Therapeutics, Inc.
1W: +1.5%
1M: +23.4%
3M: -35.5%
YTD: -42.3%
1Y: +28.0%
3Y: -24.5%
5Y: +1.6%
$17.24
-0.45 (-2.54%)
Weekly Expected Move ±18.1%
$11
$14
$17
$20
$23
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$71M
Revenue
+23382.8% YoY
$-361M
Net Income
-17.0% YoY
$-304M
Free Cash Flow
-8.4% YoY
14.2%
Gross Margin
-82389.4%
Op. Margin
-74397.9%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-51.7%
ROA-43.9%
ROIC299.3%
Valuation
P/E-4.9
P/B2.8
EV/EBITDA-3.2
Leverage
Debt/Equity0.07
Current Ratio12.65
Interest Cov.-32.7x
Quality Scores
Piotroski F3/9
Altman Z4.53
Beneish M1.92